• +1 513 549 5911 (U.S.)
  • +44 203 318 2846 (U.K.)

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports

3D Cell Culture Market

3D Cell Culture Market, By Product (Scaffold-Free (Hanging Drop, Bio Reactor), Scaffold-Based 3D Cell Culture, Microfluidics, Magnetic Levitation), By Application (Cancer, Stem Cell Research, Drug Discovery), By End User (Pharmaceutical, Bio Tech, Research)


3D cell culture is an in-vitro method where cells mature in artificially created surroundings, which resembles the in-vivo environment. This technique stimulates normal cell to distinguish, proliferate, and migrate by interacting with their three-dimensional environment. Normal polarization and distinction of epithelial cells are crucial for the placement of duct-like structures in in-vitro conditions, which can be achieved when the cells are cultivated in 3D cultures. Moreover, the synergistic effect required for the fundamental interaction of cell-cell and cell-extra cellular matrix (ECM), which can control the expression of molecules concerned in cell differentiation, is achieved in 3D cell cultures.


Market scenario
Analytical instrumental companies, private companies, pharmaceutical, and different government organizations have largely invested in the 3D cell culture projects to meet the demand of the organs development and novel drug discoveries. The heavy investments made by major companies and research organizations, growing demand for organ transplantation led to the flourishing of the market. This is proposed to be one of the important factors favoring the demand for 3D cell culture. The usage of animals in research activities and testing of health professional is ordinary since decades. However, 3D cell culture can possibly replace an animal used for research and testing. This will play a fundamental role in driving the demand for this technique during the forecast period. Definite limitations are faced by 2D cell culture technique during cellular modeling studies; 3D technique efficiently overcomes the limitations by stipulating cells with an environment that allows them to act within three dimensions. High quality of 3D over 2D cell culture method is another driver that will force the demand in the next few years. Laboratories, hospital, pharma companies, research institutes, and biotechnology entities are progressively accepting this technique for healthier results. This application is attributed to the ability of 3D cultured cells to grow more realistically compared to 2D cultured cells. One of the fashionable trends in the market today is the utilization of laboratory automation for culturing 3D cells. Small- and medium-sized pharmaceutical and laboratories players may however come across a financial challenge, as the initial investment connected with execution of 3D cell culture is costly.

Moreover, products of 3D cell culture technique mostly lack uniformity, which is another factor that may confine their demand over the forecast period. Even though, the rate of acceptance of 3D cell culture is likely to climb up during the forecast period. Increasing use of the technique in pharmaceuticals for effectively studying the effect of drug doses will also reinforce the market in the near future.
Regional analysis

North America is hoped for dominating the market followed by Europe. The large share of this geographical segment is attributed to constituents such as growing incidence of cancer, presence of a well-established pharmaceutical and biotechnology industry, fundamental assistance from the government in the form of funds and grants, accessibility of technologically innovative products and existence of key market players. The U.S. remains at the forefront of global adoption of 3D cell cultures due to large number of research laboratories and government initiatives supporting owing to the quality R&D services in the country.

The 3D cell culture market in Republic of South Africa is proposed to grow at a CAGR of 28.4% according to WHO, during the forecast period. Increment in focus of the key players on the emerging markets such as Asia-Pacific and LAMEA contributes toward the development of the market focusing on overhauling their health care system and building the healthcare centers as the root of medical tourism. Next-generation drug development activities is gaining grip in Singapore, China, India,   Malaysia, and Indonesia, which will register peak growth during forecast period due to the increasing use of 3D cell culture technology, developing health care infrastructure and rise in demand for productive medicines developed through 3D cell culture systems to treat various diseases.

Key players
Some of the major players operating in the 3D cell culture market are: 

  • Thermo Fisher sceintific (US)
  • Lonza group (Switzerland)
  • Merck and Co. (Germany)
  • Synthecon, Inc. (US)
  • ReproCELL Inc. (Japan)
  • Mimetas Inc. (Netherlands)
  • Global Cell Solutions, Inc. (US)
  • 3D Biotek LLC co.(US)
  • Kuraray Co. Ltd.(Japan)
  • Hamilton Company (US)
  • Nano3D Biosciences, Inc (US)
  • QGel Co.(Switzerland).
  • Corning Inc. (US)

Global 3D cell market has following segmentation
By Product

Scaffold-based 3D Cell Culture 

  • Hydro-gels/ECM Analogs 
  • Solid Scaffolds 
  • Micro patterned Surfaces 

Scaffold-free Cell Culture  

  • Low-adhesion Micro plates 
  • Hanging Drop Plates 
  • 3D Bio reactors 
  • 3D Petri Dishes 

Microfluidics-based 3D Cell Culture 
Magnetic levitation & 3D Bio printing 

By Application
• Cancer and Stem Cell Research 
• Drug Discovery and Toxicology 
• Tissue Engineering & Regenerative Medicine 

By End User

  • Pharmaceutical & Biotechnology Companies 
  • Research Institutes 

Based on region
North America 

  • U.S
  • Canada 
  • Mexico 

Europe

  • Spain
  • U.K
  • Germany 
  • France 
  • Italy 
  • Rest of Europe 

Asia pacific

  • China 
  • India 
  • Japan 
  • South Korea
  • Australia 
  • Rest of Asia pacific  

LAMEA

  • Brazil
  • Argentina 
  • Saudi Arabia 
  • South Africa 
  • Rest of LAMEA

									

	

Related Reports

Global Zoster Vaccine Market Insights, Forecast to 2025

In 2017, the global Zoster Vaccine market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and projec ...read more

Global Varicella Virus Vaccine Market Insights, Forecast to 2025

In 2017, the global Varicella Virus Vaccine market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, a ...read more

Global Varicella Virus Vaccine Live Market Insights, Forecast to 2025

In 2017, the global Varicella Virus Vaccine Live market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segme ...read more

Global Urology Drugs Market Insights, Forecast to 2025

This report studies the Urology Drugs market. Urology drugs is the branch of drugs that focuses on diseases of the male and female urinary-tract system and the male reproductive organs. Asia-Pacific E ...read more

Global Typhoid Vi Polysaccharide Vaccine Market Insights, Forecast to 2025

In 2017, the global Typhoid Vi Polysaccharide Vaccine market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, ...read more

Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

How To Reach Us

Reach out to our most senior Sales Professional- Jay Matthews
   +1 513 549 5911 (US)
          +44 203 318 2846 (UK)
   sales@reportsmonitor.com

Our Clients

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
--Marketing Manager at a pharma company in Belgium

Enquire Before Buying

Need to ask a quick question before buying? Please fill out this short form:

Our Features

Wide Network of Publishers

Wide Network of Publishers

Access to over 1M+ market research reports

Trusted by the Best

Trusted by the Best

50+ Clients in Fortune 500

Competitive Pricing

Competitive Pricing

Our regular promotional offers and discounts make us the most economic seller of market reports

Safe and Secure

Safe and Secure

Your payment details are protected by us.